Task A02: Murine models of Ascending UTI Infection caused by Drug-Resistant Bacteria

任务 A02：耐药细菌引起的上行性尿路感染感染的小鼠模型

• 批准号: 10216911
• 负责人: DAVID BEASLEY
• 金额: $ 27.69万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-13 至 2021-07-12
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10216911
• 关键词: Animal Model; Antimicrobial Resistance; Contracts; Development; Infection; Licensure; Standardization; drug resistant bacteria; efficacy testing; infectious disease model; mouse model; therapeutic development; Animal Model; Antimicrobial Resistance; Contracts; Development; Infection; Licensure; Standardization; drug resistant bacteria; efficacy testing; infectious disease model; mouse model; therapeutic development

This contract provides for the development and standardization of small animal models for of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.

该合同规定了针对传染病的小动物模型的开发和标准化，并可能包括对候选产品的功效测试，包括支持许可的GLP研究。